Dueling data: Amgen fires back over cost effectiveness for its cholesterol drugSTATn the defensive about the value of its pricey cholesterol medicine, Amgen (AMGN 1) released a new study 2 that argues its treatment is cost effective at about $9,700 a year, which is closely in line with the existin
